Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CG0070

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
INTRODUCTION AND OBJECTIVES: CG0070 is a selective oncolytic adenovirus that exploits retinoblastoma (Rb) pathway defects. We… Expand
Is this relevant?
2018
2018
OBJECTIVES CG0070 is a replication-competent oncolytic adenovirus that targets bladder tumor cells through their defective… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2017
2017
refusal. In the primary ITT analysis (n1⁄4406), there was a significant 34% reduction in risk of recurrence in the G arm compared… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE We assessed the safety, pharmacokinetics and anticancer activity of intravesical CG0070, a cancer selective, replication… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
271 Background: Loss of retinoblastoma (Rb) tumor suppressor activity occurs commonly in bladder cancer and leads to upregulation… Expand
Is this relevant?
2012
2012
271 Background: Loss of retinoblastoma (Rb) tumor suppressor activity occurs commonly in bladder cancer and leads to upregulation… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE The purpose of this study was to examine the tumor specificity, cytotoxicity, and granulocyte macrophage colony… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
5019 In spite of early intervention with Bacillus Calmette-Guerin (BCG) and transurethral resection (TUR), high recurrence rates… Expand
Is this relevant?